InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,507.04
(
0.98%
)
Post# of 97237
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

pharma_trader

Send PM Follow Ignore
Followers 55
Posts 1664
Boards Moderated 0
Alias Born 12/11/2012

pharma_trader

Re: Bob Stocks post# 80638

Tuesday, 07/29/2014 10:18:45 AM

Tuesday, July 29, 2014 10:18:45 AM

Post# of 97237
ADMP:"FDA Accepts for Review Adamis' New Drug Application for Its Epinephrine Pre-Filled Syringe"

Dr. Dennis Carlo, President and CEO of Adamis, stated, "This is a major milestone in that the PFS will be the company's first product to generate revenues. With the FDA's acceptance of our submission, we are anticipating the regulatory decision for marketing authorization for the PFS in the U.S. in the first half of 2015."

http://finance.yahoo.com/news/fda-accepts-review-adamis-drug-131500489.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up